Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Neurovision Receives Financing for Retinal Imaging Technology

Sep 2016
SACRAMENTO, Calif. — Imaging and diagnostic solutions provider Neurovision Imaging LLC has raised financing for regulatory approval of its retinal imaging technology for the early detection and monitoring of Alzheimer’s-related amyloid pathology.

The company’s imaging technology focuses on the retina, a developmental outgrowth of the central nervous system sharing many of the brain's characteristics, enabling the potential of retinal imaging for amyloid detection in Alzheimer's disease.

The Series B financing was led by a $5 million investment from Wildcat Capital Management. A portion of the funds is being reserved for strategic investors.

Leonard Potter, chief investment officer and president of Wildcat Capital Management, has been named to Neurovision’s board of directors.

1. The photosensitive membrane on the inside of the human eye. 2. A scanning mechanism in optical character generation.
BusinessAmericasCalifornianeurovisionBiophotonicsAlzheimer’simagingretinawildcatfundingdiagnosticspeopleleonard potterRapidScan

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!